RDY (NYSE) - Dr. Reddy’s Laboratories Ltd ADR

Exchange: USA Stocks • Country: India • Currency: USD • Type: Common Stock • ISIN: US2561352038
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. Web URL: https://www.drreddys.com

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for RDY (NYSE) - Dr. Reddy’s Laboratories Ltd ADR


Market Cap in USD 11,626m
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception 2001-04-11


Fundamental 7.51
Dividend 6.03
Performance 5y 6.10
Rel. Performance vs Sector 1.64
Analysts 4.20
Fair Price Total Ret. 65.33
Fair Price DCF todo


Growth TTM 29.98%
CAGR 5y 15.82%
CAGR / Mean Drawdown 5y 1.23
Sharpe Ratio TTM 1.27
Alpha vs SP500 TTM 21.65
Beta vs SP500 5y weekly 0.42
CAPM 6.29%
Average Daily Range 2m 1.09%
Reversal Oscillator 14.01
Volatility GJR Garch 1y 22.46%
Price / SMA 50 -2.85%
Price / SMA 200 13.42%
Current Volume 255.2k
Average Volume 20d 249.5k


Yield TTM 1.45%
Yield on Cost 5y 3.02%
Dividends CAGR 5y 5.56%
Consistency of Dividends all time 93.8%